
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
TransCelerate BioPharma Inc., and BioCelerate have come together to launch a new technology platform, DataCelerateTM, to enable R&D data sharing. DataCelerate will connect clean, converted clinical and preclinical information within One Data Lake Solution and is now accessible for the participating member companies of TransCelerate and BioCelerate.
Read the full release






